GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » CM Hospitalar SA (BSP:VVEO3) » Definitions » Research & Development

CM Hospitalar (BSP:VVEO3) Research & Development : R$0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is CM Hospitalar Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. CM Hospitalar's Research & Development for the three months ended in Mar. 2025 was R$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was R$0 Mil.

CM Hospitalar Research & Development Historical Data

The historical data trend for CM Hospitalar's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CM Hospitalar Research & Development Chart

CM Hospitalar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only - - - - -

CM Hospitalar Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CM Hospitalar Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CM Hospitalar  (BSP:VVEO3) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CM Hospitalar Research & Development Related Terms

Thank you for viewing the detailed overview of CM Hospitalar's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

CM Hospitalar Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » CM Hospitalar SA (BSP:VVEO3) » Definitions » Research & Development
Comparable Companies
BSP:PFRM3 MCK COR CAH ASX:SIG HSIC SHSE:601607 HKSE:01099 SHSE:600332 XSWX:GALE MIL:AMP NZSE:EBO SHSE:600998 TSE:7459 SHSE:600511 TSE:9987 TSE:2784 SHSE:600739 SHSE:600056 TSE:8129
Traded in Other Exchanges
N/A
Address
Avenue Luiz Maggioni, 2727, Distrito Empresarial Pref. Luiz Roberto Jabali, Ribeirao Preto, SP, BRA, 14072-055
Website
https://portal.mafrahospitalar.com.br
CM Hospitalar SA is a distributor of hospital materials and medicines in the Brazilian market.

CM Hospitalar Headlines

No Headlines